Author:
Klapper Jacob A.,Downey Stephanie G.,Smith Franz O.,Yang James C.,Hughes Marybeth S.,Kammula Udai S.,Sherry Richard M.,Royal Richard E.,Steinberg Seth M.,Rosenberg Steven
Reference27 articles.
1. SEER Database. Cancer of the Kidney and Renal Pelvis. Bethesda, MD: National Cancer Institute Surveillance, Epidemiology, and End Results Program; 2007.
2. GreeneFL,PageDL,FlemingID, et al, eds. AJCC Cancer Staging Manual. Chapter 36.6th ed. New York: Springer; 2002: 323–328.
3. Experience with the use of high‐dose interleukin‐2 in the treatment of 652 cancer patients;Rosenberg;Ann Surg.,1989
4. The use of polyethylene glycol‐modified interleukin‐2 (PEG‐IL‐2) in the treatment of patients with metastatic renal cell carcinoma and melanoma: a Phase I study and a randomized prospective study comparing IL‐2 alone versus IL‐2 combined with PEG‐IL‐2;Yang;Cancer.,1995
5. Combination therapy with interleukin‐2 and alpha‐interferon for the treatment of patients with advanced cancer;Rosenberg;J Clin Oncol.,1989
Cited by
352 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献